Berylliosis Medication

1. Sizar O, Talati R. Berylliosis (chronic beryllium disease). StatPearls [Internet]. 2020 Jan. [QxMD MEDLINE Link]. [Full Text].

2. [Guideline] Balmes JR, Abraham JL, Dweik RA, et al, for the ATS Ad Hoc Committee on Beryllium Sensitivity and Chronic Beryllium Disease. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. Am J Respir Crit Care Med. 2014 Nov 15. 190(10):e34-59. [QxMD MEDLINE Link]. [Full Text].

3. Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med. 1989 Apr 27. 320(17):1103-9. [QxMD MEDLINE Link].

4. Van Dyke MV, Martyny JW, Mroz MM, et al. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. Am J Respir Crit Care Med. 2011 Jun 15. 183(12):1680-8. [QxMD MEDLINE Link].

5. Fontenot AP, Falta MT, Kappler JW, Dai S, McKee AS. Beryllium-induced hypersensitivity: genetic susceptibility and neoantigen generation. J Immunol. 2016 Jan 1. 196(1):22-7. [QxMD MEDLINE Link]. [Full Text].

6. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science. 1993 Oct 8. 262(5131):242-4. [QxMD MEDLINE Link].

7. Kreiss K, Fechter-Leggett ED, McCanlies EC, Schuler CR, Weston A. Research to practice implications of high-risk genotypes for beryllium sensitization and disease. J Occup Environ Med. 2016 Sep. 58(9):855-60. [QxMD MEDLINE Link]. [Full Text].

8. Harber P, Su J, Alongi G. Exposure factors associated with chronic beryllium disease development in Beryllium BioBank participants. J Occup Environ Med. 2014 Aug. 56(8):852-6. [QxMD MEDLINE Link].

9. Berlin JM, Taylor JS, Sigel JE, Bergfeld WF, Dweik RA. Beryllium dermatitis. J Am Acad Dermatol. 2003 Nov. 49(5):939-41. [QxMD MEDLINE Link].

10. Barna BP, Culver DA, Yen-Lieberman B, Dweik RA, Thomassen MJ. Clinical application of beryllium lymphocyte proliferation testing. Clin Diagn Lab Immunol. 2003 Nov. 10(6):990-4. [QxMD MEDLINE Link].

11. Newman LS. Significance of the blood beryllium lymphocyte proliferation test. Environ Health Perspect. 1996 Oct. 104 Suppl 5:953-6. [QxMD MEDLINE Link].

12. Rossman MD, Kern JA, Elias JA, et al. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease. Ann Intern Med. 1988 May. 108(5):687-93. [QxMD MEDLINE Link].

13. Harber P, Su J. Beryllium Biobank 3: considerations for improving chronic beryllium disease screening. J Occup Environ Med. 2014 Aug. 56(8):861-6. [QxMD MEDLINE Link].

14. Newman LS, Buschman DL, Newell JD Jr, Lynch DA. Beryllium disease: assessment with CT. Radiology. 1994 Mar. 190(3):835-40. [QxMD MEDLINE Link].

15. Occupational Safety and Health Administration (OSHA), Department of Labor. Occupational exposure to beryllium. Final rule. Fed Regist. 2017 Jan 9. 82(5):2470-757. [QxMD MEDLINE Link]. [Full Text].

16. Jamoussi A, Merhabene T, Mlika M, et al. Interstitial pneumonia in a glassblower: think to chronic beryllium disease!. Pan Afr Med J. 2018. 31:95. [QxMD MEDLINE Link]. [Full Text].

Raed A Dweik, MD, MBA, FACP, FRCPC, FCCP, FCCM, FAHA Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Chairman, Respiratory Institute, Cleveland Clinic

Raed A Dweik, MD, MBA, FACP, FRCPC, FCCP, FCCM, FAHA is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Heart Association, American Thoracic Society, Royal College of Physicians and Surgeons of Canada, Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Zab Mosenifar, MD, FACP, FCCP Geri and Richard Brawerman Chair in Pulmonary and Critical Care Medicine, Professor and Executive Vice Chairman, Department of Medicine, Medical Director, Women's Guild Lung Institute, Cedars Sinai Medical Center, University of California, Los Angeles, David Geffen School of Medicine

Zab Mosenifar, MD, FACP, FCCP is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, American Thoracic Society

Disclosure: Nothing to disclose.

Gregg T Anders, DO Medical Director, Great Plains Regional Medical Command , Brooke Army Medical Center; Clinical Associate Professor, Department of Internal Medicine, Division of Pulmonary Disease, University of Texas Health Science Center at San Antonio

Disclosure: Nothing to disclose.

Oleh Wasyl Hnatiuk, MD Program Director, National Capital Consortium, Pulmonary and Critical Care, Walter Reed Army Medical Center; Associate Professor, Department of Medicine, Uniformed Services University of Health Sciences

Oleh Wasyl Hnatiuk, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and American Thoracic Society

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article